NASDAQ · RARE
ULTRAGENYX PHARMACEUTICAL INC (RARE) Valuation & Financials
ULTRAGENYX PHARMACEUTICAL INC (RARE) is listed on NASDAQ. Its market capitalization is about $2.5B. On trailing-twelve-month earnings the P/E ratio is -4.15. Return on equity is 258.1%. These figures are computed in-house from official filings and are reference information only.
Valuation & financial metrics
- Market cap
- $2.5B
- P/E
- -4.15
- P/S
- 3.78
- ROE
- 258.1%
Basis: Trailing twelve months · consolidated · controlling interest · 최근 4개 분기(TTM)
See the full analysis in Korean (AI committee, filings, earnings)Questions & answers
What is the P/E ratio of ULTRAGENYX PHARMACEUTICAL INC (RARE)?
On a trailing-twelve-month basis, RARE trades at a P/E ratio of -4.15. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of ULTRAGENYX PHARMACEUTICAL INC?
RARE has a market capitalization of about $2.5B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, a price forecast, or a buy or sell recommendation. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.